# A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)

Study · id `cardio:ct-nct02875639` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02875639](<https://clinicaltrials.gov/study/NCT02875639>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02875639

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT02875639. Randomized; double masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT02875639, source copy `cardio:ctgov-nct02875639-2016-08-23`, retrieved 2026-10-26)
- Start date: 2016-06 (registry gives no type) (ClinicalTrials.gov record NCT02875639, source copy `cardio:ctgov-nct02875639-2016-08-23`, retrieved 2026-10-26)
- Primary completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT02875639, source copy `cardio:ctgov-nct02875639-2016-08-23`, retrieved 2026-10-26)
- Completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT02875639, source copy `cardio:ctgov-nct02875639-2016-08-23`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02875639, source copy `cardio:ctgov-nct02875639-2016-08-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02875639-2016-08-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)
- Condition: Ischemic Heart Failure
- Intervention (Drug): Yiqi prescription
- Intervention (Drug): Huoxue prescription
- Intervention (Drug): Buyang huanwu decoction
- Intervention (Drug): QISHEN YIQI DRIPPING PILLS
- Intervention (Drug): Placebo 1
- Intervention (Drug): Placebo 2
- Lead sponsor: Zhu Mingjun
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 174db0d6f81cdc53e3ac1dfe46949ab361b72488a07fac5a54309f25cb3864a4
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
